Associate Director, Health Economics & Outcomes Research

Secura Bio was established in 2019 with a singular mission: to close the gap between innovative oncology therapies and the patients who need them most. Our high-touch approach is informed by our decades of experience shaping the impact of oncology’s largest clinical and market opportunities. We know that true impact comes from personalization and an unwavering commitment to serve patients and expand the possibilities of life-prolonging oncology medicines.

About the Role

Secura Bio is seeking a talented and motivated Associate Director of Health Economics and Outcomes Research to join our Medical Affairs organization. The ideal candidate will contribute to the generation, interpretation, and communication of outcomes and real-world evidence to support medical strategy, scientific exchange, and the articulation of clinical and patient value across the product lifecycle. As a key member of Medical Affairs, the Associate Director, HEOR will work closely with Medical Directors, Medical Science Liaisons (MSLs), Clinical Development, Biostatistics, and Market Access to ensure that robust, clinically relevant, and methodologically sound HEOR evidence supports disease education, external scientific dialogue, and evidence based decision making.

Employment Type

Full-time

Reports To

Senior Director, Global Medical Affairs Lead

Key Responsibilities

HEOR & Evidence Strategy (Medical Affairs–Led)

• Lead the development and execution of Medical Affairs aligned HEOR and real-world evidence (RWE) data generation for hematologic oncology assets across prelaunch and postlaunch phases.
• Lead and identify evidence gaps relevant to clinical practice, treatment pathways, and patient outcomes in hematologic malignancies (e.g., lymphoma, leukemia, multiple myeloma).
• Provide strategic input into Medical Affairs plans, including integrated evidence generation and scientific communication strategies.

Outcomes Research & Real-World Evidence

• Design and oversee observational studies, registries, chart reviews, and other RWE initiatives relevant to hematologic oncology populations.
• Partner with Clinical and Biostatistics teams to ensure alignment between clinical trial data and RWE generation.

Health Economics & Value Context

• Oversee the development and interpretation of health economic analyses (e.g., cost effectiveness, burden of illness, healthcare resource utilization) to contextualize clinical benefit in hematologic oncology.
• Ensure economic and outcomes evidence is scientifically rigorous, clinically meaningful, and suitable for external scientific exchange under Medical Affairs standards.
• Collaborate cross functionally to ensure consistency of value messaging while maintaining Medical Affairs independence and compliance.

Scientific Communication & External Engagement

• Lead or support development of HEOR related abstracts, posters, manuscripts, and congress submissions in hematologic oncology.
• Serve as a Medical Affairs HEOR subject matter expert to support MSL training, scientific platforms, and field medical needs.
• Support compliant scientific exchange with external experts, cooperative groups, and other stakeholders on outcomes and RWE.
• Work closely with Medical Directors, Clinical Development, Market Access, and Regulatory colleagues to ensure integrated and nonpromotional evidence planning.
• Manage external vendors and academic collaborators to ensure high quality execution of HEOR studies.
• Oversee timelines, deliverables, and budgets for assigned HEOR initiatives.

Required Qualifications

• Advanced degrees (PhD, DrPH, ScD, MD, PharmD), with experience in health economics, outcomes research, epidemiology, public health, health services research, or related fields.
• 4-6+ years of experience in HEOR, outcomes research, or RWE within pharmaceutical, biotech, consulting, or academic environments.
• Candidates with advanced scientific degrees may be considered with fewer years of industry experience.
• First-hand experience executing site-based non-interventional studies, systematic literature reviews, claims / administrative database analysis, patient-reported outcomes and health economic modeling.
• Abi…